Catheter Precision, Inc. (NYSE:VTAK) shares plummeted on Friday as traders reversed part of the stock’s recent headline-driven gains tied to its Flyte subsidiary and new patent announcements.
The decline appeared largely company-specific. The S&P 500 gained about 0.2%, while the healthcare sector slipped 0.4%.
• Catheter Precision shares are sliding. What’s pressuring VTAK stock?
What Drove VTAK’s Recent Volatility?
Earlier this week, Catheter Precision said Flyte would equip its Cirrus Vision Jet fleet with LifeVac airway-clearance devices. The stock had jumped 26.62% to 90 cents in after-hours trading on Tuesday following the announcement.
